Trial Profile
Analysis of Rho kinase (ROCK) activity in subjects with cerebrocardiovascular risk factor.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Jun 2022
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Losartan (Primary)
- Indications Essential hypertension
- Focus Biomarker; Pharmacodynamics
- Acronyms ROCK
- 01 Feb 2010 New trial record